80 related articles for article (PubMed ID: 17526917)
1. Caspofungin for the treatment of less common forms of invasive candidiasis.
Cornely OA; Lasso M; Betts R; Klimko N; Vazquez J; Dobb G; Velez J; Williams-Diaz A; Lipka J; Taylor A; Sable C; Kartsonis N
J Antimicrob Chemother; 2007 Aug; 60(2):363-9. PubMed ID: 17526917
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry.
Maertens J; Egerer G; Shin WS; Reichert D; Stek M; Chandwani S; Shivaprakash M; Viscoli C;
BMC Infect Dis; 2010 Jun; 10():182. PubMed ID: 20569436
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of caspofungin for the treatment of invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.
Li S; Li Z; Wang P; Zhan Y; Xie J; Ye F
J Int Med Res; 2024 Mar; 52(3):3000605241237878. PubMed ID: 38530040
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials.
Thompson GR; Soriano A; Honore PM; Bassetti M; Cornely OA; Kollef M; Kullberg BJ; Pullman J; Hites M; Fortún J; Horcajada JP; Kotanidou A; Das AF; Sandison T; Aram JA; Vazquez JA; Pappas PG
Lancet Infect Dis; 2024 Mar; 24(3):319-328. PubMed ID: 38008099
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study).
Rinaldi M; Bartoletti M; Bonazzetti C; Caroccia N; Gatti M; Tazza B; Horna CS; Giannella M; Viale P
Int J Antimicrob Agents; 2023 Dec; 62(6):106998. PubMed ID: 37838147
[TBL] [Abstract][Full Text] [Related]
6. Anidulafungin for Candida glabrata infective endocarditis.
De Rosa FG; D'Avolio A; Corcione S; Baietto L; Raviolo S; Centofanti P; Pasero D; Rinaldi M; Di Perri G
Antimicrob Agents Chemother; 2012 Aug; 56(8):4552-3. PubMed ID: 22644027
[No Abstract] [Full Text] [Related]
7. Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry.
Neofytos D; Huprikar S; Reboli A; Schuster M; Azie N; Franks B; Horn D
Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):135-41. PubMed ID: 23907587
[TBL] [Abstract][Full Text] [Related]
8. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
De Pauw B; Walsh TJ; Donnelly JP; Stevens DA; Edwards JE; Calandra T; Pappas PG; Maertens J; Lortholary O; Kauffman CA; Denning DW; Patterson TF; Maschmeyer G; Bille J; Dismukes WE; Herbrecht R; Hope WW; Kibbler CC; Kullberg BJ; Marr KA; Muñoz P; Odds FC; Perfect JR; Restrepo A; Ruhnke M; Segal BH; Sobel JD; Sorrell TC; Viscoli C; Wingard JR; Zaoutis T; Bennett JE; ;
Clin Infect Dis; 2008 Jun; 46(12):1813-21. PubMed ID: 18462102
[TBL] [Abstract][Full Text] [Related]
9. A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.
Betts RF; Nucci M; Talwar D; Gareca M; Queiroz-Telles F; Bedimo RJ; Herbrecht R; Ruiz-Palacios G; Young JA; Baddley JW; Strohmaier KM; Tucker KA; Taylor AF; Kartsonis NA;
Clin Infect Dis; 2009 Jun; 48(12):1676-84. PubMed ID: 19419331
[TBL] [Abstract][Full Text] [Related]
10. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Pappas PG; Kauffman CA; Andes DR; Clancy CJ; Marr KA; Ostrosky-Zeichner L; Reboli AC; Schuster MG; Vazquez JA; Walsh TJ; Zaoutis TE; Sobel JD
Clin Infect Dis; 2016 Feb; 62(4):e1-50. PubMed ID: 26679628
[TBL] [Abstract][Full Text] [Related]
11. Candida infective endocarditis: an observational cohort study with a focus on therapy.
Arnold CJ; Johnson M; Bayer AS; Bradley S; Giannitsioti E; Miró JM; Tornos P; Tattevin P; Strahilevitz J; Spelman D; Athan E; Nacinovich F; Fortes CQ; Lamas C; Barsic B; Fernández-Hidalgo N; Muñoz P; Chu VH
Antimicrob Agents Chemother; 2015 Apr; 59(4):2365-73. PubMed ID: 25645855
[TBL] [Abstract][Full Text] [Related]
12. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
[TBL] [Abstract][Full Text] [Related]
13. Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study.
Rivoisy C; Vena A; Schaeffer L; Charlier C; Fontanet A; Delahaye F; Bouza E; Lortholary O; Munoz P; Lefort A;
Clin Infect Dis; 2018 Mar; 66(6):825-832. PubMed ID: 29077791
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans.
Victorio GB; Bourdon LMB; Benavides LG; Huerta-Olvera SG; Plascencia A; Villanueva J; Martinez-Lopez E; Hernández-Cañaveral II
Mem Inst Oswaldo Cruz; 2017 May; 112(5):370-375. PubMed ID: 28443984
[TBL] [Abstract][Full Text] [Related]
15. Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.
Thompson GR; Jenks JD; Baddley JW; Lewis JS; Egger M; Schwartz IS; Boyer J; Patterson TF; Chen SC; Pappas PG; Hoenigl M
Clin Microbiol Rev; 2023 Sep; 36(3):e0001923. PubMed ID: 37439685
[TBL] [Abstract][Full Text] [Related]
16. Does
Rammaert B; Maunoury C; Rabeony T; Correas JM; Elie C; Alfandari S; Berger P; Rubio MT; Braun T; Bakouboula P; Candon S; Montravers F; Lortholary O
Front Med (Lausanne); 2022; 9():1026067. PubMed ID: 36606049
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Antifungal Activity of Echinocandins in Ascites Fluid of Critically Ill Patients.
Welte R; Oberacher H; Gasperetti T; Pfisterer H; Griesmacher A; Santner T; Lass-Flörl C; Hörtnagl C; Leitner-Rupprich S; Aigner M; Lorenz I; Schmid S; Edlinger M; Eller P; Dankl D; Joannidis M; Bellmann R
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0256520. PubMed ID: 33972242
[TBL] [Abstract][Full Text] [Related]
18. Candida Endocarditis: A Review of the Pathogenesis, Morphology, Risk Factors, and Management of an Emerging and Serious Condition.
Mamtani S; Aljanabi NM; Gupta Rauniyar RP; Acharya A; Malik BH
Cureus; 2020 Jan; 12(1):e6695. PubMed ID: 32104631
[TBL] [Abstract][Full Text] [Related]
19. Resorbable Beads Provide Extended Release of Antifungal Medication: In Vitro and In Vivo Analyses.
Hsu YH; Chen HY; Chen JC; Yu YH; Chou YC; Ueng SW; Liu SJ
Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31652891
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
